Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.

Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.

Item
http://www.wikidata.org/entity/Q36887834
The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients.FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.Trimodal therapy in squamous cell carcinoma of the esophagus.Biological imaging in the assessment of neoadjuvant treatment response in esophageal cancer: a new era?A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification.Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.Positron Emission Tomography's Utility in Esophageal Cancer ManagementSerial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours.Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients.18F-fluorodeoxyglucose positron emission tomography/computed tomography for the prediction of survival in patients with advanced esophageal cancer who have undergone neoadjuvant chemotherapy.Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.Clinical significance of SUVmax on preoperative 18F-fluorodeoxyglucose positron emission tomography in patients who underwent R0-esophagectomy for esophageal cancer
P2860

Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.

Item
http://www.wikidata.org/entity/Q36887834
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Positron emission tomographic ...... rapy for esophageal carcinoma.
@en
type
label
Positron emission tomographic ...... rapy for esophageal carcinoma.
@en
prefLabel
Positron emission tomographic ...... rapy for esophageal carcinoma.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Positron emission tomographic ...... rapy for esophageal carcinoma.
@en
P2093
P304
P31
P356
10.1016/J.ATHORACSUR.2007.03.094
P407
P433
P478
P577
P698
P921